Morgan Boren, DO
Foot and Ankle Surgery · Kingwood, TXNPI 1053816256
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $13,960 with a category attached, or 71.6%. Arthrex accounts for 78.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $12,136 and has fallen 90.4% since, to $1,164 in 2025.
Across 60 payments — averaging $232.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$11K
- Stryker$2K
- Medinc Of Texas$438
- Alafair Biosciences, Inc.$150
- Treace Medical Concepts, Inc.$139
- Acera Surgical, Inc.$133
- plus $293 from 6 others
What the payments were for
- Grants$10,00072%
- Travel & lodging$7625%
- Food & beverage$2,68719%
- Education$5114%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 16 | $10,933 |
| Stryker | 25 | $1,874 |
| Medinc Of Texas | 5 | $438 |
| Alafair Biosciences, Inc. | 1 | $150 |
| Treace Medical Concepts, Inc. | 4 | $139 |
| Acera Surgical, Inc. | 1 | $133 |
| Acumed LLC | 2 | $114 |
| Voom Medical Devices, Inc. | 1 | $89 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Smith+Nephew | 1 | $19 |
| Amgen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY ADAPTIS$511
- CITREFIX$324
- ALPHAVENT$166
- CHAMPION$166
- BIOSTEON$166
- ICONIX$166
- Actishield$161
- VersaWrap$150
- Restrata Wound Matrix$133
- 7 X 23MM CITRELOCK IMPLANT$130
- INBONE$100
How this compares
$13,960 in reported general payments places this provider in the 80th percentile of 684 foot and ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $140 |
| Meloxicam | 16 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Kingwood
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.